PeopleWith | Life Science Industry | Digital Support Programmes

Digital Patient Support Programmes.

There is growing evidence that pharmaceutical companies derive significant values from implementing patient support programmes (PSPs) in terms of treatment adherence, patient outcomes and revenue.

PeopleWith supporting Life Science organisations globally.

Empowering Life Sciences with Tailored Digital Support Programmes.

Overview:



PeopleWith provide customised digital support programs that empower life sciences companies to enhance patient engagement, improve treatment adherence and concordance, optimise outcomes and patient care. Our patient-centric platform enables the delivery of personalised support throughout patients' health journeys, while also gathering valuable real-world data to generate insights to inform market access, health economic and commercial decisions.

Key features include personalised patient engagement tailored to individual needs, real-time collection of patient-reported outcomes (PROs) for insights into health and adherence, and tools that boost treatment adherence for better health outcomes. With adaptive and scalable solutions that cater to various therapeutic areas, PeopleWith helps Life Sciences demonstrate the value of their therapies through real-world evidence. Continuous monitoring and feedback loops ensure effective communication and support for patients, ultimately driving long-term success for both patients and companies.

Here's how PeopleWith can help:


Personalised Patient Engagement:

PeopleWith enables Life Sciences to create customised digital support programmes that cater to individual patient needs, offering resources, education, and guidance based on their specific treatment pathways.

Real-time health self-monitoring (optional for individual user):

Patients accessing the digital patient support programme are presented the option to engage with their health and gain value from real-time health self-monitoring. Health data captured by the user is wholly owned by the user and is non-accessible by anyone other than the patient unless additional consents are explicitly granted.

Improved Adherence and Outcomes:

Our platforms digital tools encourage patients to stay engaged with their treatment plans, improving adherence and ultimately leading to better health outcomes.

Adaptive, Scalable Solutions:

PeopleWith flexible platform can be tailored to various therapeutic areas and adapted to different patient populations, providing scalable digital support programmes that meet diverse needs across regions and treatments.

Engagement metrics:

Engagement metric reports are shared with life science companies seeking to optimise patient-centricity with a Digital patient support program. PeopleWith enables life science companies to derive additional actionable insights into patient journeys, unmet clinical needs, and real-world market dynamics through a secure, compliant process that preserves patient privacy and eliminates the need for direct patient engagement.

Adherence to evolving materials and regulatory requirements:

Our platform enables Life Sciences to maintain ongoing communication with patients, ensuring they receive continuous support and that the programme remains effective in addressing patient concerns and improving treatment experiences.

Digital support programmes enable pharmaceutical companies to provide patients with timely, compliant updates in line with evolving regulatory requirements, ensuring that all materials are reviewed, approved, and distributed in accordance with current standards and guidance.

With PeopleWith, Life Sciences can develop innovative digital support solutions that not only enhance patient experiences but also improve therapeutic outcomes, driving long-term success for both patients and companies.


Contact us today.
"The scope of the PeopleWith Platform is further than I could have imagined and greater than I could have ever envisaged."

Global Medical Director - Top 10 Global Life Science Company